Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 17 (1) , 23-31.e3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Trends in the Use of Perioperative Chemotherapy for Localized and Locally Advanced Muscle-invasive Bladder Cancer: A Sign of Changing TidesEuropean Urology, 2015
- Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic ReviewEuropean Urology, 2014
- Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA : a contemporary population‐based analysisBJU International, 2014
- Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder CancerNew England Journal of Medicine, 2012
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 TrialJournal of Clinical Oncology, 2011
- LIFE AND DEATH OF SPARE (SELECTIVE BLADDER PRESERVATION AGAINST RADICAL EXCISION): REFLECTIONS ON WHY THE SPARE TRIAL CLOSEDBJU International, 2010
- Long-term outcome of radiation-based conservation therapy for invasive bladder cancerUrologic Oncology: Seminars and Original Investigations, 2007
- Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumoursEuropean Journal of Cancer, 2006
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990